Commentary: Phage Therapy of Staphylococcal Chronic Osteomyelitis in Experimental Animal Model

Affiliations

Comment

Stephen T Abedon. Front Microbiol. 2016.

. 2016 Aug 10:7:1251.

doi: 10.3389/fmicb.2016.01251. eCollection 2016.

No abstract available

Keywords: animal models; antibacterial agents; bacteriophages; chronic infection; phage therapy; staphylococcal infections.

Comment on

Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model.
Kishor C, Mishra RR, Saraf SK, Kumar M, Srivastav AK, Nath G. Kishor C, et al. Indian J Med Res. 2016 Jan;143(1):87-94. doi: 10.4103/0971-5916.178615. Indian J Med Res. 2016. PMID: 26997019 Free PMC article.

1. Abedon S. T. (2011). Lysis from without. Bacteriophage 1, 46–49. 10.4161/bact.1.1.13980 - DOI - PMC - PubMed
1. Capparelli R., Nocerino N., Iannaccone M., Ercolini D., Parlato M., Chiara M., et al. . (2010). Bacteriophage therapy of Salmonella enterica: a fresh appraisal of bacteriophage therapy. J. Infect. Dis. 201, 52–61. 10.1086/648478 - DOI - PubMed
1. Capparelli R., Parlato M., Borriello G., Salvatore P., Iannelli D. (2007). Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob. Agents Chemother. 51, 2765–2773. 10.1128/AAC.01513-06 - DOI - PMC - PubMed
1. Chhibber S., Gupta P., Kaur S. (2014). Bacteriophage as effective decolonising agent for elimination of MRSA from anterior nares of BALB/c mice. BMC Microbiol. 14:212. 10.1186/s12866-014-0212-8 - DOI - PMC - PubMed
1. Chibani-Chennoufi S., Sidoti J., Bruttin A., Kutter E., Sarker S., Brüssow H. (2004). In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy. Antimicrob. Agents Chemother. 48, 2558–2569. 10.1128/AAC.48.7.2558-2569.2004 - DOI - PMC - PubMed